These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 23065928)

  • 1. A fast track to personalized medicine?: whole-genome sequencing may lead to better cancer therapies.
    Nelson B
    Cancer Cytopathol; 2012 Oct; 120(5):283-4. PubMed ID: 23065928
    [No Abstract]   [Full Text] [Related]  

  • 2. Impact of genomics on personalized cancer medicine.
    Arteaga CL; Baselga J
    Clin Cancer Res; 2012 Feb; 18(3):612-8. PubMed ID: 22298893
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progress towards personalized medicine.
    Bates S
    Drug Discov Today; 2010 Feb; 15(3-4):115-20. PubMed ID: 19914397
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Era of personalized medicine may herald end of soaring cancer costs.
    Keogh B
    J Natl Cancer Inst; 2012 Jan; 104(1):12-3, 16-7. PubMed ID: 22173586
    [No Abstract]   [Full Text] [Related]  

  • 5. [Personalized treatment of cancer: utopia or chance?].
    Thiel E
    Dtsch Med Wochenschr; 2010 Sep; 135(38):1851. PubMed ID: 20842603
    [No Abstract]   [Full Text] [Related]  

  • 6. Counterpoint: Data first.
    Golub T
    Nature; 2010 Apr; 464(7289):679. PubMed ID: 20360719
    [No Abstract]   [Full Text] [Related]  

  • 7. Personalized medicine - the promised land: are we there yet?
    Li C
    Clin Genet; 2011 May; 79(5):403-12. PubMed ID: 21204795
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Refocusing the war on cancer: the critical role of personalized treatment.
    Potti A; Schilsky RL; Nevins JR
    Sci Transl Med; 2010 Apr; 2(28):28cm13. PubMed ID: 20410527
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sequencing set to alter clinical landscape.
    Hayden EC
    Nature; 2012 Feb; 482(7385):288. PubMed ID: 22337027
    [No Abstract]   [Full Text] [Related]  

  • 10. Will personalized medicine challenge or reify categories of race and ethnicity?
    Rajagopalan R; Fujimura JH
    Virtual Mentor; 2012 Aug; 14(8):657-63. PubMed ID: 23351323
    [No Abstract]   [Full Text] [Related]  

  • 11. Novel clinico-genome network modeling for revolutionizing genotype-phenotype-based personalized cancer care.
    Roukos DH
    Expert Rev Mol Diagn; 2010 Jan; 10(1):33-48. PubMed ID: 20014921
    [TBL] [Abstract][Full Text] [Related]  

  • 12. From genomic landscapes to personalized cancer management-is there a roadmap?
    Swanton C; Caldas C
    Ann N Y Acad Sci; 2010 Oct; 1210():34-44. PubMed ID: 20973797
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of genomics on the path to personalized medicine.
    Tremblay J; Hamet P
    Metabolism; 2013 Jan; 62 Suppl 1():S2-5. PubMed ID: 23021037
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Personalized medicine: the medicine of tomorrow. Foreword.
    Tremblay-Servier M
    Metabolism; 2013 Jan; 62 Suppl 1():S1. PubMed ID: 23018144
    [No Abstract]   [Full Text] [Related]  

  • 15. Making personalized cancer medicine a reality: challenges and opportunities in the development of biomarkers and companion diagnostics.
    Parkinson DR; Johnson BE; Sledge GW
    Clin Cancer Res; 2012 Feb; 18(3):619-24. PubMed ID: 22298894
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Placing bets on biotech.
    Weintraub K
    Cancer Discov; 2011 Nov; 1(6):462. PubMed ID: 22586641
    [No Abstract]   [Full Text] [Related]  

  • 17. Genetic determinants of anticancer drug activity: towards a global approach to personalized cancer medicine.
    Picker A; Jackson DB
    Expert Rev Mol Diagn; 2011 Jul; 11(6):567-77. PubMed ID: 21745011
    [TBL] [Abstract][Full Text] [Related]  

  • 18. From cancer genomics to precision oncology--tissue's still an issue.
    Cohen RL; Settleman J
    Cell; 2014 Jun; 157(7):1509-14. PubMed ID: 24949964
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Economic effects of "molecular" medicine].
    Riemann JF
    Dtsch Med Wochenschr; 2007 Aug; 132(34-35):1740. PubMed ID: 17713881
    [No Abstract]   [Full Text] [Related]  

  • 20. Grouping of molecularly targeted anti-cancer agents based on cost-effectiveness analysis.
    Tirelli U; Berretta M; Bearz A; Carbone A
    Eur Rev Med Pharmacol Sci; 2011 Nov; 15(11):1355-6. PubMed ID: 22195374
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.